Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease

Acta Neuropathologica

Volumn 91, Issue 2, 1996, Pages 174-179

  Mielke, R ^a,b   Schroder R ^b   Fink, G R ^a   Kessler, J ^a   Herholz, K ^a,b   Heiss, W D ^a,b  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Alzheimer's disease; Neurofibrillary tangles; Regional cerebral glucose metabolism; Semiquantitative neuropathology; Senile plaques

Indexed keywords

GLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; BRAIN METABOLISM; BRAIN TOMOGRAPHY; CASE REPORT; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENILE PLAQUE; TEMPORAL CORTEX;

EID: 0030053834     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050410     Document Type: Article

References (44)

1. Arnold SE, Hyman TB, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1: 103-116
2. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42: 631-639
3. 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 40: 711-714
4. Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: 797-811
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
6. Burns A, Luthert P, Levy R, Jacoby R. Lantos P (1990) Accuracy of clinical diagnosis of Alzheimer's disease. BMJ 301: 1026
7. Chase TN, Foster NL, Mansi L (1983) Alzheimer's disease and the parietal lobe. Lancet II: 225
8. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L (1988) Clinicopathologic studies in dementia: nondemented subjects with confirmed Alzheimer's disease. Neurology 38: 1682-1688
9. DeCarli C, Atack JR, Ball MJ, Kay JA, Grady CL, Fewster P, Pettigrew KD, Rapoport SI, Schapiro MB (1992) Post-mortem neurofibrillary tangle densities but not senile plaques densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients. Neurodegeneration 1: 113-121
10. Dekosky ST, Scheff SW (1990) Synapse loss in frontal-cortex biopsies in Alzheimer's disease - correlation with cognitive severity. Ann Neurol 27: 457-464
11. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ (1991) Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81: 328-335
12. Dewar D, Wyper D, Graham DI, McCulloch J (1991) Regional cerebral blood flow and quantitative neuropathology in autopsy-verified cases of Alzheimer's disease. J Cereb Blood Flow Metab 11: 18
13. Duara R, Grady C, Haxby J, Sundaram M, Cutler MR, Heston L, Moore A, Schlageter N, Rapoport SI (1986) Positron emission tomography in Alzheimer's disease. Neurology 36: 879-887
14. Duara R, Barker WW, Pascal S, Bruce-Grgorios J, Nuremberg M, Boothe T (1991) Lack of correlation of regional neuropathology to the regional PET metabolic deficits in Alzheimer's disease. J Cereb Blood Flow Metab 11: 19
15. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. J Psychiatr Res 12: 189-198
16. Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, DiChiro G (1983) Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 33: 961-965
17. 18F)fluordeoxyglucose. J Comput Assist Tomogr 7: 595-598
18. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill R, Lessin P, Thal LJ (1994) Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51: 888-895
19. Herholz K, Pawlik G, Wienhard K, Heiss WD (1985) Computer assisted mapping in quantitative analysis of cerebral positron emission tomography. J Comput Assist Tomogr 9: 154-161
20. Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss WD (1990) Accuracy of diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1: 156-164
21. Hyman BT, Van Hoesen GW, Damasio AR (1990) Memory-related neural systems in Alzheimer's disease: an anatomical study. Neurology 40: 1721-1730
22. Kennedy AM, Newman S, Clegg F, Tyrrell P, Warrington EK, Roques P, Hardy J, Rossor MN, Frackowiak RSJ (1992) Imaging in dementia: longitudinal studies using positron emission tomography. Neurobiol Aging 13: 13
23. Khachaturian AZ (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1104
24. Martin EM, Wilson RS, Penn RD, Fox JH, Clasen RA, Savoy RN (1987) Cortical biopsy results in Alzheimer's disease: correlation with cognitive deficits. Neurology 37: 1201-1204
25. McGeer PL, Kamo H, Harrop R, McGeer EG, Martin WRW, Pate BD, Li DKB (1986) Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease. Neurology 36: 1569-1574
26. McGeer PL, Kamo H, Harrop R, Li DKB, Tuokko H, McGeer EG, Adam MJ, Ammann W (1986) Positron emission tomography in patients with clinical diagnosed Alzheimer's disease. Can Med Assoc J 134: 597-607
27. McGeer EG, McGeer PL, Harrop R, Akiyama H, Kamo H (1990) Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer's disease. J Neurosci Res 27: 612-619
28. McGeer PL, McGeer EG, Akiyama H, Harrop R (1990) Regional deficits in cortical metabolism in PET-scanned Alzheimer cases correlate with postmortem biochemical indices of gliosis and not with choline acetyltransferase. Neurobiol Aging 11: 260-261
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 19: 939-944
30. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1992) Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 13: 93-98
31. Mielke R, Herholz K, Grand M, Kessler J, Heiss WD (1994) Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 5: 36-41
32. Mirra SS, Heyman A, McKeel D, Sumi SM, Cram BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41: 479-486
33. Morris JC, McKeel DW Jr, Fulling K, Torack RM, Berg L (1988) Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 24: 17-22
34. Neary D, Snowdon JS, Mann DMA, Bowen DM, Sims NR, Northern B, Yates PO, Davidson AN (1989) Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry 49: 229-237
35. Powers JM, Sclaepfer WW, Willingham MC, Hall BJ (1981) An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations. J Neuropathol Exp Neurol 40: 592-612
36. Reisberg B, Ferris SH, De Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139: 1136-1139
37. 18F)fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44: 127-137
38. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897-916
39. Sulkava R, Haltia M, Paetau A, Wilkström J. Palo J (1983) Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 46: 9-13
40. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease - synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-580
41. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. A clinicopathologic study of 57 cases. Neurology 38: 359-364
42. 18F)-2-fluoro-2-deoxy-d-glucose: a critical appraisal of optimization procedures. J Cereb Blood Flow Metab 5: 115-125
43. Wilcock GK, Esiri MM (1982) Plaques, tangles and dementia. A quantitative study. J Neurol Sci 57: 407-417
44. Wisniewski HM, Moretz RC, Lossinsky AS (1981) Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent. Ann Neurol 10: 517-522